Form 4: Spero Therapeutics CFO Esther Rajavelu Sells Shares to Cover Tax Obligations

Esther Rajavelu, CFO & CBO of Spero Therapeutics, sold shares of common stock to cover tax withholding obligations related to vesting RSUs.

Summary

• On November 7, 2024, Esther Rajavelu, CFO & CBO of Spero Therapeutics, sold 23,351 shares of common stock at a price of $1.31 per share.
• On November 8, 2024, Rajavelu sold 17,245 shares of common stock at a price of $1.30 per share.
• These transactions were executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs) granted on November 13, 2023.
• Following these transactions, Rajavelu directly owns 379,270 shares of Spero Therapeutics common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (selling shares to cover taxes on vested RSUs). It doesn't inherently indicate positive or negative sentiment regarding the company's performance.

Industry Context

Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among corporate executives and are generally not indicative of a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares by a company executive could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect.

Key Dates